Zacks: Analysts Anticipate CASI Pharmaceuticals, Inc. (NASDAQ:CASI) to Announce -$0.10 Earnings Per Share

Wall Street analysts expect that CASI Pharmaceuticals, Inc. (NASDAQ:CASI – Get Rating) will report earnings of ($0.10) per share for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for CASI Pharmaceuticals’ earnings. The highest EPS estimate is ($0.09) and the lowest is ($0.11). CASI Pharmaceuticals reported earnings per share of ($0.11) […]

Related Keywords

China ,United States , ,Geode Capital Management ,Goldman Sachs Group Inc ,Zacks Investment Research ,Susquehanna International Group ,Nasdaq ,Pharmaceuticals Get Rating ,Marshall Wace ,Cubist Systematic Strategies ,Pharmaceuticals Inc ,Wall Street ,Get Rating ,Investment Research ,International Group ,Capital Management ,Systematic Strategies ,Goldman Sachs Group ,Sachs Group ,Casi Pharmaceuticals ,Nasdaq Casi ,Casi ,Medical ,Ratings ,Consensus ,